Acitretin-induced alopecia areata: a case report

dc.contributor.authorÖzlü, Emin
dc.contributor.authorKaradağ, Ayşe Serap
dc.contributor.authorAkdeniz, Necmettin
dc.contributor.authorUzuncakmak, Tuğba Kevser
dc.date.accessioned2025-05-10T19:36:24Z
dc.date.issued2015
dc.departmentİMÜ, Fakülteler, Dahili Tıp Bilimleri Bölümü
dc.description.abstractAlopecia areata is a common form of non-scarring hair disorder. The development of alopecia areata during anti-psoriatic treatment has been reported with the systemic therapies such as infliximab, etanercept, adalimumab, alefacept and efalizumab. Retinoid-induced alopecia areata on the eyelash and eyebrow has not been reported in the literature. We report a female patient who presented with alopecia areata of the eyebrow and eyelash one month after the initiation of acitretin therapy for psoriasis.
dc.identifier.doi10.3109/15569527.2014.948684
dc.identifier.endpage250
dc.identifier.issn1556-9527
dc.identifier.issn1556-9535
dc.identifier.issue3
dc.identifier.pmid25198403
dc.identifier.scopus2-s2.0-84954125719
dc.identifier.scopusqualityQ3
dc.identifier.startpage248
dc.identifier.urihttps://doi.org/10.3109/15569527.2014.948684
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9181
dc.identifier.volume34
dc.identifier.wosWOS:000363456600002
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofCutaneous and Ocular Toxicology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectAcitretin
dc.subjectalopecia areata
dc.subjectdrug reaction
dc.titleAcitretin-induced alopecia areata: a case report
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9181.pdf
Boyut:
140.25 KB
Biçim:
Adobe Portable Document Format